The drug stock is higher over the past month while the S&P 500 has pulled back sharply.
Source link
Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply.
Source link
